EI
MRNA icon

Ethic Inc’s Moderna MRNA Stock Holding History

Ethic Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
15,694
+2,118
+16% +$110K 0.01% 686
2026
Q1 		$690K Buy
13,576
+1,392
+11% +$64.9K 0.01% 755
2025
Q4 		$359K Sell
12,184
-3,449
-22% -$93.7K 0.01% 945
2025
Q3 		$404K Sell
15,633
-9,890
-39% -$276K 0.01% 902
2025
Q2 		$693K Buy
25,523
+10,325
+68% +$272K 0.01% 723
2025
Q1 		$413K Sell
15,198
-4,129
-21% -$147K 0.01% 851
2024
Q4 		$804K Sell
19,327
-1,849
-9% -$88.4K 0.02% 659
2024
Q3 		$2.26M Sell
21,176
-3,436
-14% -$315K 0.06% 356
2024
Q2 		$2.92M Buy
24,612
+3,436
+16% +$435K 0.07% 296
2024
Q1 		$2.26M Buy
21,176
+11,383
+116% +$1.15M 0.06% 356
2023
Q4 		$974K Buy
9,793
+419
+4% +$35.2K 0.03% 546
2023
Q3 		$968K Sell
9,374
-21
-0.2% -$2.34K 0.03% 492
2023
Q2 		$1.14M Sell
9,395
-2,595
-22% -$346K 0.04% 418
2023
Q1 		$1.84M Buy
11,990
+4,524
+61% +$746K 0.07% 308
2022
Q4 		$1.34M Buy
7,466
+2,878
+63% +$471K 0.07% 317
2022
Q3 		$543K Buy
4,588
+1,571
+52% +$238K 0.04% 470
2022
Q2 		$431K Buy
3,017
+1,190
+65% +$170K 0.03% 514
2022
Q1 		$315K Sell
1,827
-2,192
-55% -$369K 0.02% 593
2021
Q4 		$1.02M Buy
+4,019
New +$1.18M 0.08% 281

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Ethic Inc's MRNA Position: Q2 2026 in Review

Ethic Inc increased its Moderna (MRNA) stake by 16% in Q2 2026, buying an estimated $110K and bringing the position to 15,694 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #686.

Ethic Inc first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.92M in Q2 2024. 247 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Ethic Inc held 15,694 shares of Moderna worth $1.1M as of Q2 2026.
  • Ethic Inc bought 2,118 Moderna shares in Q2 2026, an estimated $110K.
  • Moderna made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #686 holding.
  • Ethic Inc first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • Ethic Inc's Moderna position peaked at $2.92M in Q2 2024.
  • 247 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.